Applied Plastics is a leader in advanced catheter components including the trademarked PTFE Natural® coating applied to fine wire, forming & extrusion mandrels and pull wires.  Visit our NEW online store to purchase in stock coated mandrels, wires & hypotubes, product ships within 24 hours. For over 65 years, our lubricious and robust coatings, with tolerances held to +/- .0003”, provide the highest level of bond strength & durability to withstand the high temperatures required while manufacturing advanced catheter systems. Our smooth, lubricious coated fine wire, mandrels and hypotubes enable faster and higher quality catheter production and allow for improved navigation through the body’s tortuous anatomies. As more advanced devices are used in increasingly complex interventional procedures, medical device companies require the highest quality of PTFE coating and seek out Applied Plastics’ capabilities. Applied Plastics’ customers include the leading medical device OEMs and contract manufacturers focused on the high growth and innovative vascular catheter device market including therapy areas ranging from cardiac rhythm management (CRM), electrophysiology (EP), neurovascular, peripheral vascular and structural heart. Applied Plastics became a portfolio company of Vance Street Capital in January 2019.

Our team ‘brings it’ every day for one mission: to conquer transcription factors and create cutting-edge medicines for patients. Flare Therapeutics is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of our scientific founders, the FlareTx team is leveraging the power of ‘switch sites’ as druggable regions that hold the control for predictable and profound changes in DNA transcription, and therefore, gene expression. Our drug discovery to target ‘switch sites’ has rapidly advanced, resulting in our pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology.

Camger Coatings Systems, Inc. has been designing and manufacturing specialty coatings and adhesives in New England for more than 50 years. Our products fulfill a broad array of applications including, but not limited to, high end architectural, fine wood finishing, DTM protective, and marine coatings. We also offer contract manufacturing services to companies that would like to outsource the production of their product. We are proudly a privately owned, family oriented, people focused business. Our customers say that our greatest strengths are the quality of our products and the quality of our customer service. Come be a part of what's happening at Camger!

Transforming the right molecules into the best medicines™ Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives. We have rapidly built a portfolio of high-value candidates across multiple therapeutic areas and are actively seeking additional programs for our diverse pipeline.

Since 2003, Environmental Operating Solutions, Inc. (EOSi) has been committed to “Empowering Clean Water” and has led the industry in helping its customers to comply with increasingly stringent discharge regulations for nitrogen, phosphorous, selenium and perchlorate contamination. EOSi builds long-term partnerships with its customers by providing complete treatment solutions that typically include its proprietary, environmentally sustainable MicroC® supplemental carbon products, process monitoring and control systems, and highly qualified process engineers, who provide on-going technical support. EOSi’s goal is to ensure its customers maintain environmental permit compliance at the lowest possible cost. As a result, EOSi’s team of 30+ employees have become the #1 provider of supplemental carbon programs to the U.S. water treatment industry, serving more than 600 customer sites from a network of 20 manufacturing sites across the U.S. EOSi is based in Pocasset, Massachusetts. EOSi is part of a nutrient removal platform called Axius Water, formed by KKR and XPV Water Partners. KKR is a leading global investment firm and the platform is part of the Firm’s Global Impact strategy. XPV Water Partners is the leading private equity firm focused exclusively on making a difference in water.

Manufacturer of animal glues, technical gelatins, water based coatings and resin glue.

SwimEx manufactures the world's finest hydrotherapy pools, swim spas, and plunge tanks. We are dedicated to helping customers recover from injury, train, condition, and stay strong, for life. Founded by fiberglass pioneer Everett Pearson in 1986, SwimEx pools and plunge tanks are made in the USA and used in athletic training rooms, hospitals, physical therapy clinics, senior living facilities, health clubs and private homes. Constructed in durable fiberglass, they feature an industry-exclusive water system that creates the most even, powerful and widest water current on the market.

ZRC Worldwide is the leading manufacturer of high quality zinc rich coatings for protection of iron and steel against corrosion. Over the last 50 years our products have been included by architects and specifiers for thousands of projects throughout the world.

Novomer, Inc. is a leading developer of chemical conversion technology to address market needs for transformable, functional, and high carbon utility materials. Novomer’s current focus is in the development of beta-propiolactones and derivatives, using its proprietary Novo22™ catalyst. Our patented technology focuses on catalyst, process conversion, and polymerization techniques to provide chemical intermediates, compostable polymers, and high-performance functionalized lactones. Novomer’s investment base includes strategic investors Saudi Aramco, SABIC and DSM and financial investors Flagship Ventures, OVP Ventures, and Physic Ventures. For more information, visit www.novomer.com.

TEDOR Pharma Services is a science-driven Contract, testing, Drug Development, and Manufacturing Organization (CDMO). partnering with your team to provide solutions and services for analytical testing; drug dosage development; clinical supply, packaging, distribution; and commercial manufacturing. DEA-scheduled products I-V; high potency; powder biologics; small manufacturing batches and orphan drugs for life science customers. TEDOR has helped customers meet their project timelines, achieve regulatory approvals, and solve formulation challenges. TEDOR Pharma employs skilled and specialized experts that support a wide range of capabilities that include: •Drug Product Development • Analytical Testing • Quality Assurance • Legal Compliance • Regulatory Filing • cGMP Manufacturing • Commercialization Our dynamic work environment provides a great opportunity to learn and grow professionally. We offer competitive wages and benefits, and our employees have the opportunity to drive innovative technologies, setting industry trends. TEDOR is an Equal Opportunity Employer.

GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning. ROME was launched in April 2020 and was incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund. ROME is based in Cambridge, Mass. For more information, please visit www.rometx.com.